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Extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases are plasmid (but
also chromosomally) encoded enzymes found in Enterobacteriaceae, determining
resistance to a variety of important antibiotics including penicillins, cephalosporins,
and monobactams. In recent decades, the prevalence of ESBL/AmpC-producing
bacteria has increased rapidly across the world. Here, we evaluate the potential use
of bacteriophages in terms of a reduction of antibiotic-resistant bacteria in healthy
animals. The aim of our studies was to isolate bacteriophages capable of destroying
ESBL/AmpC-producing Escherichia coli isolated from livestock habitats. The efficacy
of isolated phages against ESBL/AmpC E. coli strains varies, but creation of a phage
cocktail with broad activity spectrum is possible. This may indicate that the role of
phages may not be limited to phage therapy, but bacterial viruses may also be applied
against spread of bacteria with antibiotic resistance genes in the environment. We
also addressed the hypothesis, that phages, effective for therapeutic purposes may
be isolated from distant places and even from different environments other than the
actual location of the targeted bacteria. This may be beneficial for practical purposes,
as the construction of effective phage preparations does not require access to disease
outbreaks.
Keywords: bacteriophages, antibiotic resistance, antibiotic resistance genes, ESBL/AmpC resistant E. coli, phage
therapy
INTRODUCTION
Extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases are plasmid and/or
chromosomally encoded enzymes found in Enterobacteriaceae, conferring resistance to different
β-lactam antibiotics, including penicillins, cephalosporins, and monobactams (Rawat and Nair,
2010). ESBL/AmpC-producing organisms are often co-, or multiresistant, exhibiting resistance
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to other anti-microbial classes including fluoroquinolones,
aminoglycosides, and trimethoprim-sulfamethoxazole (EFSA
Panel on Biological Hazards [BIOHAZ], 2011; Xu et al., 2015).
To date the most common ESBL types are TEM, SHV, and CTX-
M, which have been divided into five groups known as CTX-M-1,
CTX-M-2, CTX-M-8, CTX-M-9, and CTX-M-25 (Bonnet, 2004).
The most common plasmid-mediated AmpC type β-lactamase
worldwide is CMY-2 (Jacoby, 2009). In veterinary medicine,
ESBL-producing bacteria have been proved to cause mastitis
in dairy cattle (Timofte et al., 2014), urinary tract infections
(UTI) in companion animals (Keefe et al., 2010), and soft
skin infections in companion animals and horses (Ewers et al.,
2014). In humans, they may also cause UTI, pneumonia, or
even sepsis (Peña et al., 2006; Falagas and Karageorgopoulos,
2009).
According to the European Food Safety Authority
(EFSA), rapid emergence of resistance caused by ESBL
in Enterobacteriaceae is a major public health concern in
Europe (EFSA Panel on Biological Hazards [BIOHAZ],
2011). A report from the Infectious Diseases Society of
America from 2006 listed ESBL-producing Klebsiella spp. and
Escherichia coli among the six drug-resistant microbes for
which new therapies are urgently needed (Pitout and Laupland,
2008).
In light of the growing threat associated with the spread
of antibiotic resistance, the World Health Organization
(WHO) and the European Commission (EC) have recognized
the importance of studying anti-microbial resistance and
highlighted the need to devise appropriate strategies for
its control (Picozzi et al., 2014). Also the World Medical
Association (WMA) appealed for increased research
funding to develop new anti-microbial agents (Kelly et al.,
2011).
Application of bacteriophages to combat bacterial diseases
(phage therapy), despite its initial fast development, was
significantly marginalized after the discovery of penicillin and
other antibiotics (Sulakvelidze et al., 2001; Deresinski, 2009).
Nowadays, a rapidly growing number of drug-resistant bacterial
strains have already evolved as the most serious threats
in public health. Therefore, phage therapy is recognized as
one of the most attractive alternatives to classical antibiotic-
based treatment and is becoming an important research
objective.
Although phage therapy for the treatment of infections
caused by antibiotic-resistant bacterial strains has been
studied extensively (Biswas et al., 2002; Jensen et al.,
2015), until now only a few studies have described the
use of phages in terms of a reduction of antibiotic-
resistant bacteria in healthy animals (Teng-Hern et al.,
2014). In this study it was demonstrated that phages
may be potentially applied to reduce the prevalence of
ESBL/AmpC E. coli in healthy food-producing animals
and thus may play an important role in the ecology of
resistance. We also addressed the hypothesis that phages
for this purpose can easily be isolated from distant
places and even different environments than the targeted
bacteria.
MATERIALS AND METHODS
Environmental Samples
A total of nineteen samples were collected from six pig farms in
Poland. Depending on the particular maintenance system (litter,
deep litter, slatted floor), the samples were collected from bedding
material (litter system) (n = 7), feces (slatted floor) – pooled or
from individuals (n= 5), and feed taken from the feeders (n= 5).
Additionally, two manure samples were collected from a manure
lagoon.
Isolation of Bacteria from Environmental
Samples
From all collected environmental samples, bacteria were isolated
and subsequently used for phage isolation and host range
testing. Of each environmental sample (feces/litter/feed), 5 g
were introduced into 30 ml of LB broth (Sigma–Aldrich,
Germany) and incubated at 37◦C for 20 h. On the following
day, the overnight cultures were spread on Columbia Agar with
sheep blood (BioMerieux, France) to obtain single colonies.
All bacteria of different phenotypes were identified using the
BBL Crystal Autoreader System (BD Biosciences, USA). In
addition, the generic affiliation of bacteria to which specific
phages were isolated was confirmed with matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry analysis
(MALDI Microflex LT and Biotyper database, Bruker Daltonics,
Bremen, Germany). Subsequently, bacteriophages were isolated
from the same overnight cultures by filtration through 0.22 µm
syringe filters (Merck Millipore, Germany).
Isolation of Bacteriophages
The phage isolation was carried out using the modified method
of Slopek et al. (1972). Each of the isolated bacterial strains was
used to test for bacteriophage in each filtrate. Briefly, 5 ml of a
3-h incubated bacterial culture (LB broth) was poured out on
a LB agar plate (excess culture was removed and the plate was
left to dry) and 50 µl of each filtrate was introduced into each of
eight sectors previously marked on the bottom of the plate. After
drying of the drop, the plates were incubated at 37◦C and plaque
formation was monitored after 3, 4, 5, and 24 h.
Amplification of Bacteriophages
Isolated bacteriophages were amplified in the respective host
bacteria. Therefore, 20 µl of phage filtrate and 20 µl of the
bacterial overnight culture were added to 10 ml of LB broth and
incubated at 37◦C. The optical density (OD600) of the culture was
measured hourly. In case of an OD fall (phages eliminated most
of the bacteria), additional host bacteria were added. If the OD
increased (there were more bacteria in the culture than phages),
additional phage filtrate was added. After a total incubation time
of 6 h, all remaining bacteria were removed by filtration through
a 0.22 µm syringe filter and the phage titer was determined using
the double agar method (Adams, 1959). The experiments were
performed in triplicate in order to eliminate bactericidal activity
of some chemical compounds which might potentially be present
in the sample.
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ESBL/AmpC-Producing E. coli
Extended-spectrum β-lactamases/AmpC-producing E. coli
strains derived from the strain collection of the Institute for
Animal Hygiene and Environmental Health, Freie Universitaet
Berlin. The isolates were obtained from 7 different pig farms
(n = 104) and 22 turkey farms (n = 51) in Germany. Each
isolate originated from an individual sample including feces,
boot swabs, manure, air or dust. ESBL/AmpC E. coli were
selected using MacConkey agar (Oxoid, CM 0115, Wesel,
Germany) supplemented with 1 mg/L cefotaxime, followed by
species confirmation using MALDI-TOF identification (MALDI
Microflex LT and Biotyper database, Bruker Daltonics, Bremen,
Germany). The presence of the β-lactamase genes blaCTX,
blaTEM, blaSHV and the CIT-type AmpCs (e.g., CMY-2) was
confirmed by real-time PCR as described by Roschanski et al.
(2014).
Bacteriolytic Activity of Isolated
Bacteriophages against ESBL/AmpC
E. coli Isolated from Selective Pig and
Turkey Farms from Germany
One hundred four ESBL/AmpC E. coli strains originally
isolated from pig farms from Germany and stored at the
culture collections of the Institute for Animal Hygiene and
Environmental Health, Freie Universitaet Berlin (Berlin,
Germany) were chosen and tested for sensitivity to the 17
previously isolated bacteriophages. Additionally, 51 ESBL/AmpC
E. coli isolated from turkey farms (from the same collection)
were typed with the same phage preparations. The procedure was
performed as described in the section Isolation of bacteriophages.
Activity of Phage Cocktail against
ESBL/AmpC E. coli Isolated from Pig
Farms
Bacteriophages selected for the cocktail were mixed in the ratio
1:1:1 (V/V/V). The final titer of each phage was 1 × 109 pfu/ml.
The activity tests of the cocktail were performed as described for
the tests of the monophage preparations.
RESULTS
Occurrence of E. coli and E. coli-Specific
Bacteriophages in Pig Environment
Sampled in Polish Pig Farms
A total of 75 bacterial strains were isolated from the 19 collected
samples including: Proteus spp. (22), Escherichia ssp. (out of 23
strains 20 were E. coli), Aeromonas ssp. (5), Staphylococcus ssp.
(4), Providencia ssp. (3), Klebsiella ssp. (3), Morganella ssp. (2),
Citrobacter ssp. (2), Vibrio ssp. (2), Shigella ssp. (2), Serratia ssp.
(2), Kytococcus ssp. (1), Corynebacterium ssp. (1), Acinetobacter
ssp. (1), Aerococcus ssp. (1), Bacillus ssp. (1). A total of 19 filtrates,
one per sample, with potential bacteriophages were prepared and
the sensitivity of all isolated bacterial strains tested against each
bacteriophage. Twenty-two different bacteriophages, all specific
to E. coli, were isolated. Three rounds of successive plaque
purifications were performed to isolate each phage. Seventeen
phages were successfully amplified for further studies.
Activity of Isolated Bacteriophages
against ESBL/AmpC E. coli Isolated from
Pig Farms
The activity of 17 bacteriophages isolated from Polish pig farms
was tested against 104 ESBL/AmpC E. coli strains isolated from
German pig farms. The results showed that all phages were active
against the tested E. coli strains and they lysed from 1.9% up to
57.7% of all strains (Figure 1). 82.7% of all bacterial isolates were
sensitive to at least one of the phages, which means that 17.3%
were not sensitive to any of the phage preparations.
Activity of Phage Cocktail against ESBL
E. coli Isolated from Pig Farms
Based on the above results, a cocktail of three phages was
prepared and tested against ESBL E. coli. The cocktail included
phages BF17 and BF15, which showed the highest bactericidal
activity. Phages BF7 and BF9 showed a similar activity against
the tested E. coli strains (45.2 and 42.3%, respectively); however,
to cover a broader spectrum of bacteria, for the cocktail we
chose phage BF9 even though it showed slightly lower activity
than phage BF7. The phages from hypothetical cocktail were
characterized in terms of their morphology, genetics and phage-
bacteria kinetics (data not shown). The selected cocktail lysed
80.8% of all tested strains.
To confirm the activity of the phage cocktail, nine ESBL E. coli
strains with different sensitivity to the individual phages were
chosen. The obtained results (Table 1) confirmed that the tested
phage cocktail might potentially be useful against ESBL E. coli.
Activity of Isolated Bacteriophages
against ESBL/AmpC E. coli Isolated from
Turkey Farms
To investigate whether the 17 phages may also be active
against bacterial strains isolated from different animal farm
environments, additional host range determination using 51
randomly selected ESBL/AmpC E. coli isolated from German
turkey farms was performed. Interestingly, almost all phages
(14/17) were more active against ESBL/AmpC E. coli isolated
from turkey farms than ESBL/AmpC E. coli isolated from pig
farms. Eleven out of the 51 strains were not sensitive to any of
the phages, which means that the complete pool of phages lysed
78.4% of all tested strains (Figure 1).
DISCUSSION
The potential therapeutic applications of phages as one of
the main alternatives to classical treatment have been widely
explored. Bacteriophages have already been successfully applied
in treatment of antibiotic-resistant bacterial strains, including
methicillin-resistant Staphylococcus aureus (Jensen et al., 2015)
and vancomycin-resistant Enterococcus sp. (Biswas et al., 2002).
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FIGURE 1 | Activity of bacteriophages isolated from Polish pig farms against ESBL/AmpC Escherichia coli isolated from German pig and turkey
farms. Blue and red columns mean activity (%) of bacteriophages isolated from Polish pig farms against ESBL/AmpC E. coli isolated from German pig and turkey
farms, respectively, and the last column means activity (%) of a cocktail (BF9 + BF15 + BF17) against ESBL/AmpC E. coli isolated from German pig farms.
TABLE 1 | Activity of bacteriophage cocktail (BF9 + BF15 + BF17) against selected Extended-spectrum β-lactamase (ESBL) Escherichia coli strains.
Bacterial strain Origin β-Lactamases Previous observations Obtained result (phage cocktail)
23 Single animal feces CTX, TEM-1 No lysis caused by any of the phages No lysis
35 Single animal feces CTX No lysis caused by phages from cocktail,
but lysis caused by other phages
No lysis
36 Single animal feces CTX Active phages: BF15 + BF17 Lysis
80 Air sample (impingement) CTX Active phages: BF9 + BF15 + BF17 Lysis
86 Manure lagoon CTX, TEM-1 Active phages: BF9 + BF17 Lysis
88 Pooled feces taken in the rearing quarter CTX Active phage BF15 Lysis
89 Boot swab inside the stable CTX, TEM-1 Active phage BF17 Lysis
97 Single animal feces CTX Active phages BF9 + BF15 Lysis
103 Fly CTX Active phage BF9 Lysis
In addition, the effectiveness of phage ø9882, isolated from
hospital sewage, against a broad range of ESBL-producing E. coli
clinical isolates has been shown in mice. It is worth emphasizing
that the studies of Wang et al. (2006) provided a framework
to evaluate the therapeutic efficacy of phages against fatal ESBL
E. coli infections in humans (Wang et al., 2006). However, our
research shows that the role of phages may not be limited to phage
therapy, but bacterial viruses may also be applied against spread
of bacteria with antibiotic resistance genes in the environment.
In the first part of the present study, a total of 17
bacteriophages specific to E. coli were isolated from Polish pig
farms. Phages were isolated only with bacteria simultaneously
isolated from the same environment. In the second stage of
the study, the bactericidal activity of phages isolated from
Polish farms was evaluated against unrelated bacterial isolates
(ESBL/AmpC E. coli isolated from German pig farms). All phages
were found to be active against some of the tested strains, but they
lysed these strains with different efficacy.
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Possible activity of the isolated phages against ESBL/AmpC
E. coli from animal species other than pigs was also investigated.
However, it is worth noting that the tested strains isolated from
pig and turkey farms were not compared genetically, and thus
it is theoretically possible that the same bacteria were isolated
from both environments. Interestingly, almost all phages showed
higher or similar activity against the strains originating from
turkey compared to the pig isolates.
In the past, the focus of most phage therapy studies lay in
finding phages against specific pathogens. This was performed by
on-demand isolation methods in which targeted bacterial strains
were added to the culture to enrich potential bacteriophages.
This seems to be highly effective, since it was successfully done
with phages against Pseudomonas aeruginosa and Salmonella
but also against ESBL E. coli and Klebsiella (Mattila et al.,
2015). In this study, we addressed the hypothesis that phages,
isolated from distant places and even deriving from different farm
environments than the targeted bacteria, may also be suitable for
an efficient polyphage therapy. This is of great importance, as it
proves that the construction of effective phage preparations does
not require access to disease outbreaks.
Interestingly, the relationship between the presence of phages
and sensitive bacteria has already been observed at the stage of
phage isolation. In an initial spot tests we selected 22 potential
bacteriophages for purification (17 phages were successfully
amplified for further studies). As we analyzed the origin of these
22 phages and their hosts, 18 phages were active against bacteria
from different farms. Furthermore, to compare the effectiveness
of the on-demand method with isolation of phages from distant
locations and environments, we additionally prepared phage
filtrate obtained using this technique (Supplementary Figure 1).
To create this preparation, we used the same 51 E. coli strains
from turkey farms, which were used for activity tests of phages
from pig farms. Phage filtrate obtained using the on-demand
method lysed 80.4% of all tested strains. To compare, three
of 17 phages from Polish pig farms (BF5 + BF15 + BF17)
lysed this pool of bacteria with only slightly lower efficacy
of 78%. It is noteworthy that we did not separate individual
phages from the preparation obtained using the on-demand
method, but while testing the activity of phages against bacteria
we used the whole filtrate, which may hypothetically contain
several different phages. We may assume that after isolation
of individual phages it would not be possible to create a
3-phage cocktail with similar efficiency as the one from pig
farms.
The results of this study confirmed previous observations
of Jensen et al. (2015), who demonstrated that phages active
against human methicillin-resistant and methicillin-susceptible
S. aureus may be easily isolated from chicken sources, which
are not necessarily predicted to be a good source of phages
against these bacteria. Notably, in contrast to our studies, these
phages were isolated using the on-demand method. Gutiérrez
et al. (2016) found no clear association of infectivity of phages
against S. aureus strains based on the geographic region of host
or phage isolation. However, the authors postulated a possible
association between phage infectivity and the environment. This
was also mentioned by Vos et al. (2009), who suggested that
phages may adapt to become more effective against bacteria living
closely.
Although person-to-person spread is recognized as the
main method of dissemination of ESBL/AmpC bacteria in the
community, the prevalence of ESBLs nowadays has increased
significantly due to E. coli isolates from food-producing animals
(Carattoli, 2008; Geser et al., 2012; Samanta et al., 2015).
Furthermore, the ESBL/AmpC-producing E. coli in animal farms
could influence public health through environmental pollution
(Li et al., 2015). Fecal emission and the airborne route might
be possible ways of ESBL/AmpC emission into the environment
(Yuan et al., 2010; Friese et al., 2013; Laube et al., 2014). Moreover,
vectors such as flies (Usui et al., 2013) or small rodents (Kozak
et al., 2009) may also spread anti-microbial resistance. The
landform may also boost the dissemination of bacteria, as they
may be spread with the rainfall from farms situated in the hills.
In addition, if antibiotics are used in the farms, residues can enter
the waterways and be transferred to distant locations, creating an
antibiotic resistance problem in new locations. As bacteriophages
may be transmitted in the environment via similar pathways,
the spread of phages and host bacteria may have a wide range.
This may be one explanation why active phages may be isolated
from distant locations and different environments than targeted
bacteria.
Another possibility is that phages become lysogenic during
transmission in the environment and they revert back to lytic
ones at distant places. They may originate from farms other than
the one from which they were isolated.
Higher activity of phages from distant farms and
environments than in the case of co-isolates may be due to
the occurrence in different environments and the lack of direct
contact that would result in the development of resistance
to phages, as observed in phage-treated campylobacteriosis
(Loc Carrillo et al., 2005). The phenomenon of bacterial phage
resistance is, however, complex and probably depends on the
phage-bacteria configuration and time points of interactions
occurring between bacterial viruses and their hosts (Fischer
et al., 2013). The data regarding phage resistance are scarce and
contradictory; thus detailed studies to explain this phenomenon
need to be conducted.
Although the results of this study indicate the relation
between the geographic distance and type of environment from
which active phages are isolated, they are not sufficient for the
conclusion that a particular source is better for the isolation
of effective phages. Studies including the use of samples from
several different environments and locations would be more
reliable, especially considering the contradictory data in the
literature.
The present study indicated that bacterial viruses have a
potential for prevention or treatment of E. coli with ESBL genes.
Moreover, they may be good candidates in control strategies
against the widespread presence of ESBL/AmpC E. coli in
healthy food-producing animals and hence the reduction of these
bacteria in the entire food chain. Phages for this purpose may be
easily isolated from the environment, but the question whether
distant locations and different environments are better sources of
active phages remains open. Although phages are considered one
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of the least known entities on our planet (Grose et al., 2014) and
further studies regarding their biology need to be conducted, they
undoubtedly could provide a novel approach to the prevention
and treatment of infections caused by drug-resistant bacteria.
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